
Dennis Miller, R.Ph. is a retired chain store pharmacist. His book, The Shocking Truth About Pharmacy: A Pharmacist Reveals All the Disturbing Secrets, can be downloaded in its entirety at Amazon for 99 cents.
A Phrase Past Its Expiration Date
“Side effects” may be the most successful euphemism in medicine. The phrase sounds tidy, almost architectural: the desired action occupies the center, while everything inconvenient is pushed toward the margins. Relief is the main event; dizziness, bleeding, insomnia, nausea, sexual dysfunction, confusion, dependence, or organ damage are supporting details.
But a body does not sort drug actions into center stage and the wings. A pharmaceutical enters a biological system and produces effects. Some are intended. Some are unwanted. Some are predictable, some rare, some mild, some catastrophic. None becomes biologically peripheral because a label calls it “side.”
The term has outlived its usefulness. It should be eliminated from serious clinical communication and replaced with language that tells patients what actually matters.
“Side” Is Not a Scientific Category
The distinction between a desired effect and a “side effect” is often a distinction of purpose, not mechanism. A sedating antihistamine may be taken for allergies, making drowsiness unwanted. The same sedating action can be marketed or used to help with sleep. The molecule did not change. The context did.
Minoxidil was developed as a blood-pressure drug; hair growth was once an unintended effect and later became the commercial centerpiece of another product (Rogaine). Sildenafil was studied for cardiovascular purposes before its effect on erections became the headline (Viagra). Botulinum toxin can reduce muscle spasm, smooth wrinkles (Botox), or contribute to swallowing difficulty. Which action gets called “side” depends on the treatment goal, the dose, the patient, and sometimes the market.
That instability reveals the flaw. “Side effect” does not name a separate class of pharmacology. It names an effect someone has ranked as secondary.
The “Side” Effect Can Become the Main Event
For the person living through it, an unwanted effect may matter more than the symptom the drug was prescribed to treat. An opioid may reduce pain yet also suppress breathing, cause constipation, cloud attention, and create dependence. An anticoagulant may reduce the likelihood of a clot while increasing bleeding. Insulin lowers blood glucose, but too much can produce dangerous hypoglycemia. A corticosteroid may calm inflammation while raising blood sugar, disturbing sleep, thinning bone, or increasing infection risk.
An antidepressant may improve mood while causing nausea, emotional blunting, sleep disruption, or sexual dysfunction. A stimulant may improve concentration while reducing appetite or increasing heart rate. A diuretic may lower blood pressure while producing frequent urination, dehydration, or electrolyte disturbance. A chemotherapy drug may attack a tumor while also injuring rapidly dividing healthy cells.
These are not trivial appendages to the “real” treatment. They are part of the treatment’s total biological and human consequence.
Language Quietly Tilts the Consent Process
Words establish hierarchy before the facts arrive. “Benefit and side effects” sounds like a comparison between a central good and peripheral nuisances. “Expected benefits, burdens, and risks” is harder to wave away. It makes clear that every outcome belongs in the same decision.
This matters because informed consent is not merely the delivery of a warning list. It is a discussion of tradeoffs. A 1 percent chance of a severe event may matter more to one patient than a 30 percent chance of a modest benefit. Fatigue may be tolerable to someone seeking short-term symptom relief and unacceptable to someone whose livelihood requires sustained alertness. Weight change, tremor, diarrhea, cognitive slowing, or reduced libido may be labeled “nonserious” in a trial yet become decisive in daily life.
Calling these outcomes “side effects” can subtly instruct patients to endure them, feel embarrassed about raising them, or assume they are the price of being properly treated.
A Convenience That Protects the Center
The phrase persists because it is short, familiar, and useful to institutions. Package inserts can group unwanted outcomes under a recognizable heading. Advertisements can race through them while the imagery returns to smiling patients. Clinicians can use the term as conversational shorthand. Researchers can separate efficacy endpoints from adverse events.
Convenience, however, is not neutrality. The wording preserves the perspective of the prescriber, manufacturer, or study design: the intended outcome sits at the center because the institution placed it there. The patient’s experience is then arranged around that intention.
Medicine should resist language that makes a treatment goal sound more real than the effects required to pursue it.
Not Every Effect Is Equally Important
Rejecting “side effects” does not mean flattening every outcome into equivalence. A dry mouth is not the same as internal bleeding. Temporary drowsiness is not the same as a life-threatening rhythm disturbance. Good communication must distinguish probability, severity, duration, reversibility, timing, and uncertainty.
But that is precisely why “side effect” is inadequate. It combines too much and explains too little. It can refer to a mild inconvenience, a reason to stop treatment, a permanent injury, or a medical emergency. A phrase that broad conceals the distinctions patients need.
Say What Kind of Effect You Mean
The solution is not silence. It is precision. Clinicians, labels, journalism, and advertising should use terms that describe the effect’s relationship to the treatment and its practical significance:
· Intended effects: the outcomes the treatment is meant to produce.
· Unwanted effects: outcomes the patient or clinician would prefer to avoid.
· Adverse effects: harmful or medically unfavorable outcomes.
· Common treatment effects: effects frequently observed, whether helpful or troublesome.
· Serious risks: outcomes with grave potential consequences.
· Withdrawal or rebound effects: outcomes associated with reducing or stopping a drug.
· Interactions: effects produced or altered by another drug, food, supplement, or condition.
Plain language can go further: “This drug may reduce inflammation, and it may also raise blood sugar and infection risk.” The conjunction “and” is more honest than the hierarchy hidden inside “but.” All of those actions belong to the drug’s profile.
Retire the Euphemism
Pharmaceuticals do not know which of their actions we intended. Receptors do not read marketing copy. Livers do not distinguish a primary claim from fine print. A drug has effects because it interacts with a body; our purposes do not divide those effects into biologically central and peripheral categories.
Medicine can keep the necessary distinctions—beneficial or harmful, intended or unintended, common or rare, tolerable or intolerable—without keeping a misleading umbrella term. In fact, abandoning “side effects” would force better distinctions.
The phrase should be retired not because every drug is dangerous, nor because treatment lacks value, but because honest decisions require honest framing. Drugs can relieve suffering, prevent disability, and save lives. They can also impose burdens and create risks. Both truths belong in the center.
There are no side effects. There are effects. The responsible task is to name them, measure them, compare them, and decide which ones a patient is willing to accept.
Dennis Miller, R.Ph. is a retired chain store pharmacist. His book, The Shocking Truth About Pharmacy: A Pharmacist Reveals All the Disturbing Secrets, can be downloaded in its entirety at Amazon for 99 cents.